Evidence map›Paper›PMID 35096800›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Immobilization of β-Galactosidase by Encapsulation of Enzyme-Conjugated Polymer Nanoparticles Inside Hydrogel Microparticles.

Narmin Suvarli, Lukas Wenger, Christophe Serra, Iris Perner-Nochta, Jürgen Hubbuch, Michael Wörner

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. A Cholesterol Analogue for Cell-Surface Enzyme Display.Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Narmin SuvarliBiomoleular Separation Engineering, Institute of Process Engineering in Life Sciences, Department of Chemical and Process Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Lukas WengerBiomoleular Separation Engineering, Institute of Process Engineering in Life Sciences, Department of Chemical and Process Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Christophe SerraChimie Macromoléculaire de Précision, Institute Charles Sadron, Université de Strasbourg, Strasbourg, France.
Iris Perner-NochtaBiomoleular Separation Engineering, Institute of Process Engineering in Life Sciences, Department of Chemical and Process Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Jürgen HubbuchBiomoleular Separation Engineering, Institute of Process Engineering in Life Sciences, Department of Chemical and Process Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Michael WörnerBiomoleular Separation Engineering, Institute of Process Engineering in Life Sciences, Department of Chemical and Process Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Karlsruhe Institute of Technology · DEUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing the shelf life of enzymes and making them reusable is a prominent topic in biotechnology. The encapsulation inside hydrogel microparticles (HMPs) can enhance the enzyme's stability by preserving its native conformation and facilitating continuous biocatalytic processes and enzyme recovery. In this study, we present a method to immobilize β-galactosidase by, first, conjugating the enzyme onto the surface of polymer nanoparticles, and then encapsulating these enzyme-conjugated nanoparticles (ENPs) inside HMPs using microfluidic device paired with UV-LEDs. Polymer nanoparticles act as anchors for enzyme molecules, potentially preventing their leaching through the hydrogel network especially during swelling. The affinity binding (through streptavidin-biotin interaction) was used as an immobilization technique of β-galactosidase on the surface of polymer nanoparticles. The hydrogel microparticles of roughly 400 μm in size (swollen state) containing unbound enzyme and ENPs were produced. The effects of encapsulation and storage in different conditions were evaluated. It was discovered that the encapsulation in acrylamide (AcAm) microparticles caused an almost complete loss of enzymatic activity. Encapsulation in poly(ethylene glycol) (PEG)-diacrylate microparticles, on the other hand, showed a residual activity of 15-25%, presumably due to a protective effect of PEG during polymerization. One of the major factors that affected the enzyme activity was presence of photoinitiator exposed to UV-irradiation. Storage studies were carried out at room temperature, in the fridge and in the freezer throughout 1, 7 and 28 days. The polymer nanoparticles showcased excellent immobilization properties and preserved the activity of the conjugated enzyme at room temperature (115% residual activity after 28 days), while a slight decrease was observed for the unbound enzyme (94% after 28 days). Similar trends were observed for encapsulated ENPs and unbound enzyme. Nevertheless, storage at -26°C resulted in an almost complete loss of enzymatic activity for all samples.

Indexed as

affinity bindingbiofunctionalizationenzyme activitymicrofluidicsPEG-diacrylatephotopolymerization

Identifiers

PMID35096800
PMCPMC8793669
OpenAlexW4206560100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.